LLNI Funded Publications
The histone deacetylase inhibitor Romidepsin induces as a cascade of differential gene expression and altered Histone H3K9 marks in myeloid leukaemia cells.
Author:Clarke K
Other Authors: Young C, Liberante F, McMullin MF, Thompson A, Mills K,
Last Updated:16/12/2019
Source:a
Type:Journal Article
DOI:10.18632/oncotarget.26877
Journal:Oncotarget
Date: 2019